Advertisement

Topics

Octapharma USA Announces FDA Approval of NUWIQ® New Product Strengths, Expanding Hemophilia A Patient Treatment Options

10:03 EDT 22 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New Higher Vial Strengths will Provide Added Dosing Flexibility & Convenience Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved new product strengths for NUWIQ®, ...

Other Sources for this Article

Yankee Public Relations
Fred Feiner, 908-425-4878
fred@yankeepr.com

NEXT ARTICLE

More From BioPortfolio on "Octapharma USA Announces FDA Approval of NUWIQ® New Product Strengths, Expanding Hemophilia A Patient Treatment Options"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...